Dr Ina Rudloff was recruited to the Ritchie Centre at Monash University where she researches the function and therapeutic potential of novel immune modulators of the interleukin (IL-1) family. She completed her PhD in theoretical medicine with a focus on immunology at the Goethe University in Germany. Ina’s research has the goal of influencing clinical practice in the treatment of severe inflammatory conditions.